Skip to main content
. 2024 Jun 22;16(13):2300. doi: 10.3390/cancers16132300

Figure 10.

Figure 10

Inhibition of HDAC activity increases the ability of cisplatin to eliminate metastatic cancer cells and reduce the tumor clusters in pediatric liver cancers. The diagram shows a summary of the results presented in this manuscript. Right images show typical images observed on the experimental plates.